These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17388867)

  • 21. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.
    Davidson MB; Thakkar S; Hix JK; Bhandarkar ND; Wong A; Schreiber MJ
    Am J Med; 2004 Apr; 116(8):546-54. PubMed ID: 15063817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathogenesis, diagnostics and therapy of gout].
    Zurek M
    Vnitr Lek; 2006; 52(7-8):736-41. PubMed ID: 16967617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rasburicase (Fasturtec)].
    Vogt B; Gugger M; Frey FJ
    Ther Umsch; 2004 Sep; 61(9):579-82. PubMed ID: 15493120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gouty arthritis. A primer on late-onset gout.
    Ene-Stroescu D; Gorbien MJ
    Geriatrics; 2005 Jul; 60(7):24-31. PubMed ID: 16026179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
    Iakunina IA; Barskova VG; Nasonova VA
    Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370
    [No Abstract]   [Full Text] [Related]  

  • 27. Pipeline Therapies for Gout.
    Yip K; Braverman G; Yue L; Fields T
    Curr Rheumatol Rep; 2024 Mar; 26(3):69-80. PubMed ID: 38133712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rasburicase: a review of its use in the management of anticancer therapy-induced hyperuricaemia.
    Oldfield V; Perry CM
    Drugs; 2006; 66(4):529-45. PubMed ID: 16597166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyperuricemia].
    Chizyński K; Rózycka M
    Pol Merkur Lekarski; 2005 Nov; 19(113):693-6. PubMed ID: 16498814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allopurinol-induced DRESS syndrome.
    Markel A
    Isr Med Assoc J; 2005 Oct; 7(10):656-60. PubMed ID: 16259349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gout].
    Leclercq P; Malaise MG
    Rev Med Liege; 2004 May; 59(5):274-80. PubMed ID: 15264576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years.
    Darmawan J; Rasker JJ; Nuralim H
    J Rheumatol; 2003 Nov; 30(11):2437-43. PubMed ID: 14677190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gout: a review of its aetiology and treatment.
    Li EK
    Hong Kong Med J; 2004 Aug; 10(4):261-70. PubMed ID: 15299172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.
    Ganson NJ; Kelly SJ; Scarlett E; Sundy JS; Hershfield MS
    Arthritis Res Ther; 2006; 8(1):R12. PubMed ID: 16356199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug therapy for idiopathic hyperuricemia--introduction, dose, and side effects].
    Yamanaka H
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():202-8. PubMed ID: 12629718
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism.
    Takahashi S; Moriwaki Y; Yamamoto T; Tsutsumi Z; Ka T; Fukuchi M
    Ann Rheum Dis; 2003 Jun; 62(6):572-5. PubMed ID: 12759298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal arthritis. Gout and pseudogout in the geriatric patient.
    Cassetta M; Gorevic PD
    Geriatrics; 2004 Sep; 59(9):25-30; quiz 31. PubMed ID: 15461235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition and management of gout and hyperuricemia.
    Yennie RH
    JAAPA; 2003 Mar; 16(3):21-4, 27-8, 31. PubMed ID: 14968523
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic factors associated with gout and hyperuricemia.
    Bleyer AJ; Hart TC
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):124-30. PubMed ID: 16580613
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.